ANNA WAGNER: Open Payments
NPI 1497307557 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,375 in 283 payments from 50 companies in 2025. Trend: 2023 $5,549 · 2024 $5,917 · 2025 $6,375
Food & beverage: $6,136Education: $312
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 41 | $1,045 |
| AstraZeneca Pharmaceuticals LP | 19 | $476 |
| Novartis Pharmaceuticals Corporation | 27 | $340 |
| Boston Scientific Corporation | 4 | $296 |
| Merck Sharp & Dohme LLC | 11 | $288 |
| Daiichi Sankyo Inc. | 11 | $212 |
| Eisai Inc. | 13 | $208 |
| GlaxoSmithKline, LLC. | 12 | $205 |
| JAZZ PHARMACEUTICALS INC. | 3 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $183 |
Products named: ENHERTU, RYBREVANT, KEYTRUDA, TALVEY, SARCLISA, ERLEADA, Lenvima, TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial).
Industry payments across TX — which companies pay providers there.
